Fluvoxamine for the treatment of anxiety disorders in children and adolescents.
暂无分享,去创建一个
[1] D. Pine,et al. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. , 2001, The New England journal of medicine.
[2] C. Grillon,et al. Vulnerability factors among children at risk for anxiety disorders , 1999, Biological Psychiatry.
[3] F. Champagne,et al. The role of corticotropin-releasing factor–norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress , 1999, Biological Psychiatry.
[4] D. Pine,et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. , 1998, Archives of general psychiatry.
[5] L. Crockett,et al. The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. , 1995, Journal of child psychology and psychiatry, and allied disciplines.